NX-13 Catalog No.:M15889-10 InChi: InChI=1S/C31H38N2O10/c1-32(31(37)42-22-27-25-8-4-2-6-23(25)24-7-3-5-9-26(24)27)13-15-39-17-19-41-21-20-40-18-16-38-14-12-30(36)43-33-28(34)10-11-29(33)35/h2-9

InChi: InChI=1S/C31H38N2O10/c1-32(31(37)42-22-27-25-8-4-2-6-23(25)24-7-3-5-9-26(24)27)13-15-39-17-19-41-21-20-40-18-16-38-14-12-30(36)43-33-28(34)10-11-29(33)35/h2-9

an acyclic retinoid

and stable small molecule that transcriptionally induces TRAIL in a p53-independent manner and crosses the blood-brain barrier

Chemical Name: 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid

NX-13 Catalog No.:M15889-10 InChi: InChI=1S/C31H38N2O10/c1-32(31(37)42-22-27-25-8-4-2-6-23(25)24-7-3-5-9-26(24)27)13-15-39-17-19-41-21-20-40-18-16-38-14-12-30(36)43-33-28(34)10-11-29(33)35/h2-9NX 13 is a first in class, orally active and gut restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX 13 results in lower inflammation and responses in inflammatory bowel disease. NX 13 can be used for the research of crohn's disease and ulcerative colitis. Product information CAS Number: 2389235 01 0 Molecular Weight: 399. 44 Formula: C24H21N3O3 Chemical Name: 2 {3, 5 bis[(6 methylpyridin 2